• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rational design of stable lyophilized protein formulations: theory and practice.

作者信息

Carpenter John F, Chang Beyong S, Garzon-Rodriguez William, Randolph Theodore W

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA.

出版信息

Pharm Biotechnol. 2002;13:109-33. doi: 10.1007/978-1-4615-0557-0_5.

DOI:10.1007/978-1-4615-0557-0_5
PMID:11987749
Abstract
摘要

相似文献

1
Rational design of stable lyophilized protein formulations: theory and practice.稳定冻干蛋白质制剂的合理设计：理论与实践
Pharm Biotechnol. 2002;13:109-33. doi: 10.1007/978-1-4615-0557-0_5.
2
Rational design of stable lyophilized protein formulations: some practical advice.稳定冻干蛋白质制剂的合理设计：一些实用建议。
Pharm Res. 1997 Aug;14(8):969-75. doi: 10.1023/a:1012180707283.
3
Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.冷冻和冷冻干燥在药物制剂中的应用。
Adv Exp Med Biol. 2018;1081:371-383. doi: 10.1007/978-981-13-1244-1_20.
4
Development of stable lyophilized protein drug products.稳定的冻干蛋白药物产品的开发。
Curr Pharm Biotechnol. 2012 Mar;13(3):471-96. doi: 10.2174/138920112799361990.
5
Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?冷冻干燥和储存过程中糖类对蛋白质的稳定机制：天然结构的保留、特异性相互作用和/或固定于玻璃态基质？
J Pharm Sci. 2005 Jul;94(7):1427-44. doi: 10.1002/jps.20364.
6
A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.冻干单克隆抗体的储存稳定性需要稳定剂与蛋白质的特定摩尔比。
J Pharm Sci. 2001 Mar;90(3):310-21. doi: 10.1002/1520-6017(200103)90:3<310::aid-jps6>3.0.co;2-r.
7
Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation.一种基于稳定冻干病毒样颗粒的疫苗制剂的合理设计。
Drug Dev Ind Pharm. 2009 Jan;35(1):83-97. doi: 10.1080/03639040802192806.
8
Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.在干燥和液体储存期间用于开发两种稳定冻干蛋白的制剂的物理特性表征。
Eur J Pharm Biopharm. 2005 Aug;60(3):335-48. doi: 10.1016/j.ejpb.2005.02.013.
9
Application of infrared spectroscopy to development of stable lyophilized protein formulations.红外光谱在稳定冻干蛋白质制剂研发中的应用。
Eur J Pharm Biopharm. 1998 May;45(3):231-8. doi: 10.1016/s0939-6411(98)00005-8.
10
Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.基于L-精氨酸/蔗糖的蛋白质制剂的冷冻干燥，第2部分：基于L-精氨酸氯化物的蛋白质制剂系统的配方设计和冷冻干燥工艺条件的优化
J Pharm Sci. 2015 Dec;104(12):4241-4256. doi: 10.1002/jps.24658. Epub 2015 Sep 30.

引用本文的文献

1
Anomalous Clouding Behavior of Polysorbate 80─Deciphering the Role of Nonesterified Components.聚山梨醇酯80的异常浑浊行为——解析未酯化成分的作用
Mol Pharm. 2025 Jun 2;22(6):2917-2926. doi: 10.1021/acs.molpharmaceut.4c01268. Epub 2025 May 14.
2
Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.生物治疗药物中的聚山梨酯降解酶——现状与未来展望
Front Bioeng Biotechnol. 2025 Jan 10;12:1490276. doi: 10.3389/fbioe.2024.1490276. eCollection 2024.
3
Practical advice in the development of a lyophilized protein drug product.
冻干蛋白质药物产品开发中的实用建议。
Antib Ther. 2024 Nov 21;8(1):13-25. doi: 10.1093/abt/tbae030. eCollection 2025 Jan.
4
A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations.美国批准的商业化高浓度抗体药物产品的系统评价：制剂组成、剂型设计和初级包装考虑因素。
MAbs. 2023 Jan-Dec;15(1):2205540. doi: 10.1080/19420862.2023.2205540.
5
Prediction of Unwanted Crystallization of Freeze-Dried Protein Formulations Using α-Relaxation Measurements.利用α弛豫测量预测冻干蛋白质制剂的不期望结晶
Pharmaceutics. 2023 Feb 20;15(2):703. doi: 10.3390/pharmaceutics15020703.
6
Enhanced Stability of Vegetal Diamine Oxidase with Trehalose and Sucrose as Cryoprotectants: Mechanistic Insights.海藻糖和蔗糖作为冷冻保护剂提高植物二胺氧化酶稳定性的机制研究。
Molecules. 2023 Jan 19;28(3):992. doi: 10.3390/molecules28030992.
7
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.蛋白质治疗药物中用于蛋白质稳定化的替代辅料：克服聚山梨酯的局限性
Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.
8
Application of Lyophilized Gene-Delivery Formulations to Dental Implant Surfaces: Non-Cariogenic Lyoprotectant Preserves Transfection Activity of Polyplexes Long-Term.冻干基因递呈制剂在牙种植体表面的应用：非致龋性冷冻保护剂长期保持多聚物复合物的转染活性。
J Pharm Sci. 2023 Jan;112(1):83-90. doi: 10.1016/j.xphs.2022.11.008. Epub 2022 Nov 11.
9
Impact of Formulation Choices on the Freeze-Drying of an Interleukin-6 Reference Material.
Front Mol Biosci. 2022 Jul 4;9:868460. doi: 10.3389/fmolb.2022.868460. eCollection 2022.
10
Effect of Buffer Salts on Physical Stability of Lyophilized and Spray-Dried Protein Formulations Containing Bovine Serum Albumin and Trehalose.缓冲盐对含牛血清白蛋白和海藻糖的冻干和喷雾干燥蛋白制剂物理稳定性的影响。
Pharm Res. 2023 Jun;40(6):1355-1371. doi: 10.1007/s11095-022-03318-7. Epub 2022 Jun 28.